4//SEC Filing
Reardon Tighe 4
Accession 0001209191-21-041041
CIK 0001817713other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:11 PM ET
Size
14.6 KB
Accession
0001209191-21-041041
Insider Transaction Report
Form 4
Reardon Tighe
Acting Chief Financial Officer10% Owner
Transactions
- Conversion
Common Stock
2021-06-15+2,696,843→ 2,696,843 total(indirect: See footnote) - Conversion
Common Stock
2021-06-15+1,153,238→ 3,850,081 total(indirect: See footnote) - Purchase
Common Stock
2021-06-15$17.00/sh+629,411$10,699,987→ 4,479,492 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2021-06-15−900,264→ 0 total(indirect: See footnote)→ Common Stock (1,153,238 underlying) - Conversion
Series A Convertible Preferred Stock
2021-06-15−2,105,264→ 0 total(indirect: See footnote)→ Common Stock (2,696,843 underlying)
Holdings
- 172,935
Common Stock
Footnotes (3)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
- [F2]Shares are held by Avalon BioVentures SPV I, LP (ABV SPV). ABV SPV I GP LLC (ABV GP) is a general partner of ABV SPV and may be deemed to have voting and investment power with respect to the shares held by ABV SPV and as a result may be deemed to have beneficial ownership of such shares. Mr. Reardon is Chief Financial Officer of Avalon Ventures and shares voting and investment power with respect to the shares held by ABV SPV. Mr. Reardon disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein, if any. if any.
- [F3]The shares were purchased in the Issuer's initial public offering.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001760431
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:11 PM ET
- Size
- 14.6 KB